GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Establishment Labs Holdings ESTA · USD

Health Care · US listing · 🇺🇸 United States

Compare

68.52

+2.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Establishment Labs Holdings

From its filings with the US Securities and Exchange Commission

SEC filings

Establishment Labs Holdings is based in Alajuela, Costa Rica and is incorporated in Virgin Islands, British. Its shares trade on Nasdaq under the ticker ESTA. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $211.1m and a net loss of $51.1m. At that date it held total assets of $357.2m and shareholders' equity of $23.5m. By region, EMEA (Europe / Middle East / Africa) accounted for 43.1%, followed by North America at 21.6% and Latin America at 18.9%.

In its own words

We are a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. We initially incorporated in Costa Rica in 2004 and subsequently reorganized in 2013 under a parent holding company in the British Virgin Islands.

Our line of silicone gel-filled breast implants, branded as Motiva Implants, is the centerpiece of our medical technology platform. Our 5-year results from our Motiva U.S. IDE study as well as our patient and practitioner reported post-market surveillance data indicate that Motiva Implants have low rates of adverse events (including rupture, capsular contracture, and implant-related reoperations) that compare favorably with those of our competitors. We believe these proprietary technologies that differentiate our Motiva Implants result in improved safety and aesthetic outcomes and thus drive our revenue growth.

Since launching Motiva Implants in October 2010, the majority of our revenue has been generated from sales of our Motiva Implants. To date, our Motiva Implants are registered to be sold in over 100 countries, including our line of SmoothSilk Round and SmoothSilk Ergonomix Round Implants recently approved in the United States. Our portfolio of products are commercially available via exclusive distributors or our direct sales force and includes five product families of Motiva Implants: (i) Round and Ergonomix Round, (ii) Ergonomix Oval, (iii) Anatomical TrueFixation, (iv) Ergonomix2 Round and Ergonomix2 Diamond and (v) Flora Tissue Expander.

Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
19 Jul 2018
Employees
1,004
Head office
BUILDING B15 AND 25 COYOL FREE ZONE, ALAJUELA, G2, 20101
Incorporated in
D8
Classification
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Nicholas LewinNon-Executive Chairman of the Board$224,962
  • Mr. Filippo CaldiniChief Executive Officer, Director, since 2024$1.2m
  • Mr. Rajbir DenhoyChief Financial Officer$1.1m
  • Mr. S. Ross MansbachChief Compliance Officer, General Counsel$1.1m
  • Mr. Juan Jose Chacon QuirosDirector, since 2013$2.6m
  • Ms. Ann CustinIndependent Director$202,462
  • Ms. Leslie GillinIndependent Director$190,670
  • Mr. Edward SchutterIndependent Director$209,166
  • Mr. Bryan SlotkinIndependent Director$197,928

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
77
Environment
79
Social
97
Governance
54
Women in the workforce
51%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Establishment Labs Holdings Inc has several strengths that position it positively in the market. These include:

Weaknesses

  • Despite its strengths, Establishment Labs Holdings Inc faces certain weaknesses that may hinder its growth and success:

Opportunities

  • Establishment Labs Holdings Inc has several opportunities for expansion and market growth:

Threats

  • Several threats exist in the external environment that may impact Establishment Labs Holdings Inc:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.